| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Ko-143 | CTRPv2 | pan-cancer | AAC | -0.0025 | 1 |
| mRNA | BRD-K02492147 | CTRPv2 | pan-cancer | AAC | -0.0026 | 1 |
| mRNA | etoposide | GDSC1000 | pan-cancer | AAC | 0.0021 | 1 |
| mRNA | doxorubicin:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0019 | 1 |
| mRNA | Zibotentan | GDSC1000 | pan-cancer | AAC | 0.0019 | 1 |
| mRNA | regorafenib | CTRPv2 | pan-cancer | AAC | -0.0021 | 1 |
| mRNA | Docetaxel | gCSI | pan-cancer | AAC | -0.0027 | 1 |
| mRNA | FGIN-1-27 | CTRPv2 | pan-cancer | AAC | 0.0038 | 1 |
| mRNA | isoliquiritigenin | CTRPv2 | pan-cancer | AAC | -0.0033 | 1 |
| mRNA | PLX4720 | CCLE | pan-cancer | AAC | -0.002 | 1 |